Alzamend Neuro ALZN
NASDAQ ALZN
$1.25 -0.05 (-3.85%)
At close: Oct 21, 2026 · 4:00 PM EDT

Alzamend Neuro (ALZN) Receivables - Other (2020 - 2022)

Updated

Alzamend Neuro (ALZN) posted Receivables - Other of $9,413 for fiscal Q1 2023 (quarter ended Jul 31, 2022), down 41.9% from $16,210 a year earlier.

Analysis

Alzamend Neuro (ALZN) Receivables - Other (2020 - 2022) Analysis & Trends

At the end of FY2021 (ended Apr 30, 2021), Alzamend Neuro's Receivables - Other came in at $16,210, down 83.9% from FY2020.

  • In prior fiscal years, Alzamend Neuro's Receivables - Other was $100,915 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Alzamend Neuro 5.73 Mn -9.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2022 9,413.00
Oct 31, 2021 16,210.00
Jul 31, 2021 16,210.00
Apr 30, 2021 16,210.00
Apr 30, 2020 100,915.00
API Access

Alzamend Neuro Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ALZN&period=max&api_key=YOUR_API_KEY